Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Cureus|May 19, 2025
Peritoneal Metastasis Mimicking Chemotherapy-Induced Complications in Lung Adenocarcinoma: A Diagnostic Challenge of a Case ReportRyuichi Ohta, Kaoru Tanaka, Masayuki Miyata, et al.
Cancers|July 24, 2014
Targeting MET Amplification as a New Oncogenic DriverHisato Kawakami, Isamu Okamoto, Wataru Okamoto, et al.
ESMO Open|August 2, 2017
Peritumoural ground-glass opacity associated with tumour pseudoprogression in a patient with non-small cell lung cancer treated with nivolumabRyoji Kato, Hidetoshi Hayashi, Junko Tanizaki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 1, 2011
MET tyrosine kinase inhibitor crizotinib (PF-02341066) shows differential antitumor effects in non-small cell lung cancer according to MET alterationsJunko Tanizaki, Isamu Okamoto, Kunio Okamoto, et al.
BMC Research Notes|December 20, 2013
Regression of brain metastases from breast cancer with eribulin: a case reportHiromichi Matsuoka, Junji Tsurutani, Junko Tanizaki, et al.
Cureus|April 28, 2025
Paraneoplastic Syndromes Mimicking Dermatomyositis and Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Syndrome in Cancer of Unknown Primary Origin: A Case ReportShoji Mochizuki, Ryuichi Ohta, Yuki Konya, et al.
Molecular Cancer Therapeutics|April 29, 2010
Synergistic antitumor effect of S-1 and HER2-targeting agents in gastric cancer with HER2 amplificationJunko Tanizaki, Isamu Okamoto, Ken Takezawa, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2016
Report of two cases of pseudoprogression in patients with non-small cell lung cancer treated with nivolumab-including histological analysis of one case after tumor regressionJunko Tanizaki, Hidetoshi Hayashi, Masatomo Kimura, et al.
Molecular Cancer Therapeutics|June 10, 2010
Enhanced anticancer effect of the combination of BIBW2992 and thymidylate synthase-targeted agents in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptorKen Takezawa, Isamu Okamoto, Junko Tanizaki, et al.
Frontiers in Oncology|September 26, 2025
Case Report: A small cell lung cancer transformed from an <i>EGFR</i>-mutated Adenocarcinoma demonstrated a long-term remission to anti PD-1 antibodyYusuke Kawanaka, Kimio Yonesaka, Junko Tanizaki, et al.
Pageof 7